Skip to main content
SpringerLink
Log in
Book cover

Pre-Menopause, Menopause and Beyond pp 261–268Cite as

GSM/VVA: Advances in Understanding and Management

  • Chapter
  • First Online:

Part of the book series: ISGE Series ((ISGE))

Abstract

Many millions of postmenopausal women continue to suffer in silence from symptoms resulting from oestrogen-deficient atrophy of the vulva, vagina and urinary tract, whilst the medical profession continues to debate what the condition should be called, how it should be assessed and whether it should be universally treated. It is time that a unified approach was adopted by all medical societies to reach a consensus on definitions, recognition and management. With the development of the GSM nomenclature, advances in GSM assessment tools and quality-of-life questionnaires and novel therapeutic interventions, the signs are positive that a new era is finally dawning.

This is a preview of subscription content, log in via an institution.

References

  1. Portman DJ, Gass ML (2014) Vulvovaginal atrophy terminology consensus conference panel. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s sexual health and the North American Menopause Society. Menopause 21(10):1063–1068

    Article  PubMed  Google Scholar 

  2. Nappi RE, Palacios S (2014) Impact of vulvovaginal atrophy on sexual health and quality of life at postmenopause. Climacteric 17(1):3–9

    Article  CAS  PubMed  Google Scholar 

  3. Nappi RE, Kokot-Kierepa M (2012) Vaginal health: insights, views & attitudes (VIVA)–results from an international survey. Climacteric 15:36–44

    Article  CAS  PubMed  Google Scholar 

  4. Nappi RE, Palacios S, Particco M, Panay N (2016) The REVIVE (REal Women’s VIews of treatment options for menopausal vaginal ChangEs) survey in Europe: country-specific comparisons of postmenopausal women’s perceptions, experiences and needs. Maturitas 91:81–90

    Article  PubMed  Google Scholar 

  5. Laumann EO, Paik A, Rosen RC (1999) Sexual dysfunction in the United States: prevalence and predictors. JAMA 281(6):537–544

    Article  CAS  PubMed  Google Scholar 

  6. Bachmann GA, Notelovitz M, Kelly SJ et al (1992) Long-term non-hormonal treatment of vaginal dryness. Clin Pract Sex 8:12

    Google Scholar 

  7. Erekson EA, Yip SO, Wedderburn TS, Martin DK, Li FY, Choi JN, Kenton KS, Fried TR (2013) The vulvovaginal symptoms questionnaire: a questionnaire for measuring vulvovaginal symptoms in postmenopausal women. Menopause 20(9):973–979

    Article  PubMed  PubMed Central  Google Scholar 

  8. Huang AJ, Gregorich SE, Kuppermann M, Nakagawa S, Van Den Eeden SK, Brown JS, Richter HE, Walter LC, Thom D, Stewart AL (2015) Day-to-day impact of vaginal aging questionnaire: a multidimensional measure of the impact of vaginal symptoms on functioning and well-being in postmenopausal women. Menopause 22(2):144–154

    Article  PubMed  PubMed Central  Google Scholar 

  9. Panay N. (2016). VVA from neglect to new treatment paradigm. IMS World Congress Prague. (Symposium)

    Google Scholar 

  10. Nappi RE, Panay N, Bruyniks N, Castelo-Branco C, De Villiers TJ, Simon JA (2015) The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy. Climacteric 18(2):233–240

    Article  CAS  PubMed  Google Scholar 

  11. Sturdee DW, Panay N, International Menopause Society Writing Group (2010) Recommendations for the management of postmenopausal vaginal atrophy. Climacteric 13:509–522

    Article  CAS  PubMed  Google Scholar 

  12. Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause 20(9):888–902

    Google Scholar 

  13. Gambacciani M, Levancini M, Cervigni M (2015) Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Climacteric 18(5):1–19

    Article  Google Scholar 

  14. Labrie F, Archer DF, Bouchard C, Girard G, Ayotte N, Gallagher JC, Cusan L, Baron M, Blouin F, Waldbaum AS, Koltun W, Portman DJ, Côté I, Lavoie L, Beauregard A, Labrie C, Martel C, Balser J, Moyneur É, Members of the VVA Prasterone Group (2015) Prasterone has parallel beneficial effects on the main symptoms of vulvovaginal atrophy: 52-week open-label study. Maturitas 81(1):46–56

    Article  CAS  PubMed  Google Scholar 

  15. Edwards D, Panay N (2016) Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric 19(2):151–161

    Google Scholar 

  16. Palacios S, Mejía A, Neyro JL (2015) Treatment of the genitourinary syndrome of menopause. Climacteric 18(Suppl 1):23–29

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Specialist in Reproductive Medicine, Imperial College Healthcare, London, UK

    Nick Panay B.Sc., FRCOG, MFSRH (Consultant Gynaecologist, Consultant Gynaecologist, Honorary Senior Lecturer)

  2. Specialist in Reproductive Medicine, Chelsea and Westminster Hospital, London, UK

    Nick Panay B.Sc., FRCOG, MFSRH (Consultant Gynaecologist, Consultant Gynaecologist, Honorary Senior Lecturer)

  3. Imperial College, London, UK

    Nick Panay B.Sc., FRCOG, MFSRH (Consultant Gynaecologist, Consultant Gynaecologist, Honorary Senior Lecturer)

Authors
  1. Nick Panay B.Sc., FRCOG, MFSRH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nick Panay B.Sc., FRCOG, MFSRH .

Editor information

Editors and Affiliations

  1. Professor emeritus for Gynaecological Endocrinology and Reproductive Medicine, University of Bern, Bern, Switzerland

    Martin Birkhaeuser

  2. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

Rights and permissions

Reprints and permissions

Copyright information

© 2018 International Society of Gynecological Endocrinology

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Panay, N. (2018). GSM/VVA: Advances in Understanding and Management. In: Birkhaeuser, M., Genazzani, A. (eds) Pre-Menopause, Menopause and Beyond. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-63540-8_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-63540-8_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-63539-2

  • Online ISBN: 978-3-319-63540-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation